Geneos Wealth Management’s iShares iBonds Dec 2024 Term Corporate ETF IBDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,584
| Closed | -$39.9K | – | 2981 |
|
|
2024
Q3 | $39.9K | Hold |
1,584
| – | – | ﹤0.01% | 1280 |
|
|
2024
Q2 | $39.8K | Hold |
1,584
| – | – | ﹤0.01% | 1146 |
|
|
2024
Q1 | $39.7K | Hold |
1,584
| – | – | ﹤0.01% | 1148 |
|
|
2023
Q4 | $39.5K | Hold |
1,584
| – | – | ﹤0.01% | 1136 |
|
|
2023
Q3 | $39.2K | Hold |
1,584
| – | – | ﹤0.01% | 1148 |
|
|
2023
Q2 | $39K | Hold |
1,584
| – | – | ﹤0.01% | 1154 |
|
|
2023
Q1 | $39K | Hold |
1,584
| – | – | ﹤0.01% | 1145 |
|
|
2022
Q4 | $38.7K | Hold |
1,584
| – | – | ﹤0.01% | 1136 |
|
|
2022
Q3 | $38K | Sell |
1,584
-1,000
| -39% | -$24.7K | ﹤0.01% | 1121 |
|
|
2022
Q2 | $64K | Sell |
2,584
-300
| -10% | -$7.46K | ﹤0.01% | 1178 |
|
|
2022
Q1 | $72K | Hold |
2,884
| – | – | ﹤0.01% | 1217 |
|
|
2021
Q4 | $74K | Hold |
2,884
| – | – | ﹤0.01% | 1299 |
|
|
2021
Q3 | $75K | Buy |
2,884
+1,584
| +122% | +$41.7K | ﹤0.01% | 1291 |
|
|
2021
Q2 | $34K | Hold |
1,300
| – | – | ﹤0.01% | 1659 |
|
|
2021
Q1 | $34K | Hold |
1,300
| – | – | ﹤0.01% | 1825 |
|
|
2020
Q4 | $34K | Hold |
1,300
| – | – | ﹤0.01% | 1654 |
|
|
2020
Q3 | $34K | Sell |
1,300
-200
| -13% | -$5.29K | ﹤0.01% | 1419 |
|
|
2020
Q2 | $39K | Hold |
1,500
| – | – | ﹤0.01% | 1333 |
|
|
2020
Q1 | $36K | Hold |
1,500
| – | – | ﹤0.01% | 1251 |
|
|
2019
Q4 | $38K | Hold |
1,500
| – | – | ﹤0.01% | 1405 |
|
|
2019
Q3 | $38K | Hold |
1,500
| – | – | ﹤0.01% | 1318 |
|
|
2019
Q2 | $38K | Hold |
1,500
| – | – | ﹤0.01% | 1336 |
|
|
2019
Q1 | $37K | Sell |
1,500
-430
| -22% | -$10.5K | ﹤0.01% | 1293 |
|
|
2018
Q4 | $46K | Sell |
1,930
-600
| -24% | -$14.3K | ﹤0.01% | 1137 |
|
|
2018
Q3 | $60K | Buy |
2,530
+430
| +20% | +$10.4K | ﹤0.01% | 1086 |
|
|
2018
Q2 | $50K | Sell |
2,100
-430
| -17% | -$10.4K | ﹤0.01% | 1046 |
|
|
2018
Q1 | $61K | Buy |
2,530
+2,100
| +488% | +$51.6K | 0.01% | 924 |
|
|
2017
Q4 | $10K | Hold |
430
| – | – | ﹤0.01% | 1649 |
|
|
2017
Q3 | $10K | Hold |
430
| – | – | ﹤0.01% | 1592 |
|
|
2017
Q2 | $10K | Hold |
430
| – | – | ﹤0.01% | 1554 |
|
|
2017
Q1 | $10K | Hold |
430
| – | – | ﹤0.01% | 1498 |
|
|
2016
Q4 | $10K | Hold |
430
| – | – | ﹤0.01% | 1442 |
|
|
2016
Q3 | $11K | Hold |
430
| – | – | ﹤0.01% | 1349 |
|
|
2016
Q2 | $10K | Buy |
+430
| New | +$10.8K | ﹤0.01% | 1341 |
|
Other funds holding IBDP
Geneos Wealth Management's IBDP Position: Q4 2024 in Review
Geneos Wealth Management sold out of iShares iBonds Dec 2024 Term Corporate ETF (IBDP) in Q4 2024, closing a stake of 1,584 shares — an estimated $39.9K sold.
Geneos Wealth Management first reported a position in IBDP in Q2 2016 and held it in 34 quarters. The position peaked at $75K in Q3 2021. 2 funds tracked by Wall St. Rank hold IBDP as of Q4 2024.
- Geneos Wealth Management reported no remaining iShares iBonds Dec 2024 Term Corporate ETF position as of Q4 2024 after selling out during the quarter.
- Geneos Wealth Management sold 1,584 iShares iBonds Dec 2024 Term Corporate ETF shares in Q4 2024, an estimated $39.9K.
- Geneos Wealth Management first reported a position in iShares iBonds Dec 2024 Term Corporate ETF in Q2 2016 and held it in 34 quarters.
- Geneos Wealth Management's iShares iBonds Dec 2024 Term Corporate ETF position peaked at $75K in Q3 2021.
- 2 funds tracked by Wall St. Rank held iShares iBonds Dec 2024 Term Corporate ETF as of Q4 2024.
Based on Geneos Wealth Management's 13F filing for Q4 2024, filed 21 Jan 2025.